[Research progress of in vivo bioreactor for bone tissue engineering]
- PMID: 33998218
- PMCID: PMC8175201
- DOI: 10.7507/1002-1892.202012083
[Research progress of in vivo bioreactor for bone tissue engineering]
Retraction in
-
关于《用于骨组织工程的体内生物反应器研究进展》的撤稿声明.Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022 Jan 15;36(1):9. doi: 10.7507/1002-1892.202200001. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022. PMID: 35187924 Free PMC article. Chinese. No abstract available.
Abstract
Objective: To review the research progress of in vivo bioreactor (IVB) for bone tissue engineering in order to provide reference for its future research direction.
Methods: The literature related to IVB used in bone tissue engineering in recent years was reviewed, and the principles of IVB construction, tissue types, sites, and methods of IVB construction, as well as the advantages of IVB used in bone tissue engineering were summarized.
Results: IVB takes advantage of the body's ability to regenerate itself, using the body as a bioreactor to regenerate new tissues or organs at injured sites or at ectopic sites that can support the regeneration of new tissues. IVB can be constructed by tissue flap (subcutaneous pocket, muscle flap/pocket, fascia flap, periosteum flap, omentum flap/abdominal cavity) and axial vascular pedicle (axial vascular bundle, arteriovenous loop) alone or jointly. IVB is used to prefabricate vascularized tissue engineered bone that matched the shape and size of the defect. The prefabricated vascularized tissue engineered bone can be used as bone graft, pedicled bone flap, or free bone flap to repair bone defect. IVB solves the problem of insufficient vascularization in traditional bone tissue engineering to a certain extent.
Conclusion: IVB is a promising method for vascularized tissue engineered bone prefabrication and subsequent bone defect reconstruction, with unique advantages in the repair of large complex bone defects. However, the complexity of IVB construction and surgical complications hinder the clinical application of IVB. Researchers should aim to develop a simple, safe, and efficient IVB.
目的: 对用于骨组织工程的体内生物反应器( in vivo bioreactor,IVB)的研究进展进行综述,为后续研究提供参考。.
方法: 查阅近年来骨组织工程 IVB 相关文献,从 IVB 构建原则、构建 IVB 的组织类型、部位及方法,以及 IVB 用于构建组织工程骨的优劣等方面进行综述。.
结果: IVB 是利用机体自我再生能力,把身体作为生物反应器在损伤部位或能够支持新组织再生的异位部位再生新组织或器官。IVB 可由组织瓣(皮下袋、肌瓣/袋、筋膜瓣、骨膜瓣、大网膜瓣/腹腔)和轴向血管蒂(轴向血管束、动静脉环)单独或联合构建。使用 IVB 能预构与骨缺损形状、大小匹配的血管化组织工程骨。预构的骨组织可作为游离骨移植物、带蒂骨瓣或游离骨瓣修复骨缺损。IVB 解决了传统骨组织工程血管化不足的问题。.
结论: IVB 是一种有临床应用前景的血管化组织工程骨预构和骨缺损修复重建的方法,在修复大型复杂骨缺损方面有着独特优势。但因 IVB 存在构建复杂以及手术并发症等问题影响了其临床应用,后续需致力于开发一种简单、安全、高效的 IVB。.
Keywords: In vivo bioreactor; bone tissue engineering; prefabrication; vascularization.
Conflict of interest statement
利益冲突:所有作者声明,在课题研究和文章撰写过程中不存在利益冲突。课题经费支持没有影响文章观点。
Figures
Similar articles
-
Periosteal Flaps Enhance Prefabricated Engineered Bone Reparative Potential.J Dent Res. 2022 Feb;101(2):166-176. doi: 10.1177/00220345211037247. Epub 2021 Sep 11. J Dent Res. 2022. PMID: 34514892 Free PMC article.
-
Prefabrication of a functional bone graft with a pedicled periosteal flap as an in vivo bioreactor.Sci Rep. 2017 Dec 21;7(1):18038. doi: 10.1038/s41598-017-17452-5. Sci Rep. 2017. PMID: 29269864 Free PMC article.
-
Osteocutaneous flap prefabrication based on the principle of vascular induction: an experimental and clinical study.Plast Reconstr Surg. 2000 Apr;105(4):1304-13. doi: 10.1097/00006534-200004000-00008. Plast Reconstr Surg. 2000. PMID: 10744219
-
Bone Graft Prefabrication Following the In Vivo Bioreactor Principle.EBioMedicine. 2016 Oct;12:43-54. doi: 10.1016/j.ebiom.2016.09.016. Epub 2016 Sep 20. EBioMedicine. 2016. PMID: 27693103 Free PMC article. Review.
-
In Vivo Bone Tissue Engineering Strategies: Advances and Prospects.Polymers (Basel). 2022 Aug 8;14(15):3222. doi: 10.3390/polym14153222. Polymers (Basel). 2022. PMID: 35956735 Free PMC article. Review.
References
-
- Sharma S, Sapkota D, Xue Y, et al Delivery of VEGFA in bone marrow stromal cells seeded in copolymer scaffold enhances angiogenesis, but is inadequate for osteogenesis as compared with the dual delivery of VEGFA and BMP2 in a subcutaneous mouse model. Stem Cell Res Ther. 2018;9(1):23. doi: 10.1186/s13287-018-0778-4. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources